新冠病毒感染所致嗅觉丧失：机制与意义
Anosmia in COVID-19: Mechanisms and Significance.
作者信息
Han Albert Y, Mukdad Laith, Long Jennifer L, Lopez Ivan A
机构信息
UCLA Department of Head and Neck Surgery, Los Angeles, CA.
Greater Los Angeles VA Healthcare System, Los Angeles, CA.
出版信息
Chem Senses. 2020 Jun 17. doi: 10.1093/chemse/bjaa040.
Abstract
The global pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 remains a challenge for prevention due to asymptomatic or paucisymptomatic patients. Anecdotal and preliminary evidence from multiple institutions shows that these patients present with a sudden onset of anosmia without rhinitis. We aim to review the pathophysiology of anosmia related to viral upper respiratory infections and the prognostic implications. Current evidence suggests that SARS-CoV-2-related anosmia may be a new viral syndrome specific to COVID-19 and can be mediated by intranasal inoculation of SARS-CoV-2 into the olfactory neural circuitry. The clinical course of neuroinvasion of SARS-CoV-2 is yet unclear, however an extended follow up of these patients to assess for neurological sequelae including encephalitis, cerebrovascular accidents and long-term neurodegenerative risk may be indicated.
摘要
由严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）引起的2019年冠状病毒病（COVID-19）全球大流行，由于无症状或症状轻微的患者，仍然是预防方面的一项挑战。来自多个机构的传闻和初步证据表明，这些患者会突然出现嗅觉丧失且无鼻炎症状。我们旨在综述与病毒性上呼吸道感染相关的嗅觉丧失的病理生理学及其预后意义。目前的证据表明，与SARS-CoV-2相关的嗅觉丧失可能是一种特定于COVID-19的新型病毒综合征，可通过将SARS-CoV-2经鼻接种到嗅觉神经回路来介导。然而，SARS-CoV-2神经侵袭的临床过程尚不清楚，不过可能需要对这些患者进行长期随访，以评估包括脑炎、脑血管意外和长期神经退行性风险在内的神经系统后遗症。
相似文献
1
Anosmia in COVID-19: Mechanisms and Significance.新冠病毒感染所致嗅觉丧失：机制与意义
Chem Senses. 2020 Jun 17. doi: 10.1093/chemse/bjaa040.
2
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.SARS-CoV-2 的神经入侵、嗜神经性和神经炎症事件：了解 COVID-19 患者的神经表现。
Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28.
3
Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?COVID-19 嗅觉丧失和嗅觉功能障碍是否会增加载脂蛋白 E4 患者未来患痴呆症的风险？
Med Hypotheses. 2021 Feb;147:110479. doi: 10.1016/j.mehy.2020.110479. Epub 2021 Jan 5.
4
Mechanisms of SARS-CoV-2-associated anosmia.SARS-CoV-2 相关嗅觉丧失的机制。
Physiol Rev. 2023 Oct 1;103(4):2759-2766. doi: 10.1152/physrev.00012.2023. Epub 2023 Jun 21.
5
Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.COVID-19 中的脑炎综合征和嗅觉丧失：这些临床表现真的反映了 SARS-CoV-2 的嗜神经性吗？基于 25 例 COVID-19 病例回顾的理论。
J Med Virol. 2021 Jan;93(1):550-558. doi: 10.1002/jmv.26309. Epub 2020 Jul 27.
6
Presentation of new onset anosmia during the COVID-19 pandemic.在 COVID-19 大流行期间出现新发嗅觉丧失。
Rhinology. 2020 Jun 1;58(3):295-298. doi: 10.4193/Rhin20.116.
7
Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19).嗅觉丧失：2019 年冠状病毒病（COVID-19）神经免疫中的缺失环节。
Rev Neurosci. 2020 Oct 25;31(7):691-701. doi: 10.1515/revneuro-2020-0039.
8
Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health Significance.嗅觉功能障碍：具有公共卫生意义的 COVID-19 高度普遍症状
Otolaryngol Head Neck Surg. 2020 Jul;163(1):12-15. doi: 10.1177/0194599820926464. Epub 2020 May 5.
9
A Systematic Review on Neurological Aspects of COVID-19: Exploring the Relationship Between COVID-19-Related Olfactory Dysfunction and Neuroinvasion.关于新型冠状病毒肺炎神经学方面的系统评价：探索新型冠状病毒肺炎相关嗅觉功能障碍与神经侵袭之间的关系
Front Neurol. 2022 Jul 15;13:887164. doi: 10.3389/fneur.2022.887164. eCollection 2022.
10
Zebrafish as a Translational Model: An Experimental Alternative to Study the Mechanisms Involved in Anosmia and Possible Neurodegenerative Aspects of COVID-19?斑马鱼作为一种转化模型：研究嗅觉丧失和 COVID-19 可能神经退行性方面相关机制的实验替代方法？
eNeuro. 2021 Jun 2;8(3). doi: 10.1523/ENEURO.0027-21.2021. Print 2021 May-Jun.
引用本文的文献
1
Long COVID-19-related and non-COVID-19 postviral olfactory dysfunction a comparative MRI study focusing on the olfactory cleft and bulbs.长新冠相关和非新冠病毒感染后嗅觉功能障碍：一项聚焦于嗅裂和嗅球的对比性MRI研究
Front Neurol. 2025 Jan 15;15:1535699. doi: 10.3389/fneur.2024.1535699. eCollection 2024.
2
Persistent Post-COVID-19 Olfactory Dysfunction and Its Association with Autonomic Nervous System Function: A Case-Control Study.新冠后持续性嗅觉功能障碍及其与自主神经系统功能的关联：一项病例对照研究
Diseases. 2024 Dec 28;13(1):4. doi: 10.3390/diseases13010004.
3
Evaluating the Predictors of Persistent Long COVID Symptoms and Their Severity in COVID-19 Survivors 1 Year After Infection.评估 COVID-19 感染者感染 1 年后持续性长新冠症状及其严重程度的预测因素。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241295686. doi: 10.1177/21501319241295686.
4
Humans without a sense of smell breathe differently.人没有嗅觉时呼吸方式不同。
Nat Commun. 2024 Oct 22;15(1):8809. doi: 10.1038/s41467-024-52650-6.
5
Determinants of persistence and recovery of chronic coronavirus disease 2019 chemosensory dysfunction.2019年慢性冠状病毒病化学感应功能障碍持续存在和恢复的决定因素。
J Allergy Clin Immunol. 2025 Jan;155(1):120-134. doi: 10.1016/j.jaci.2024.08.027. Epub 2024 Sep 11.
6
Receptors Involved in COVID-19-Related Anosmia: An Update on the Pathophysiology and the Mechanistic Aspects.与 COVID-19 相关的嗅觉丧失的受体：病理生理学和机制方面的最新进展。
Int J Mol Sci. 2024 Aug 5;25(15):8527. doi: 10.3390/ijms25158527.
7
Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer's Disease.减少新冠病毒在大脑中的淀粉样蛋白沉积并预防新冠病毒加剧的痴呆症和阿尔茨海默病的潜在策略。
Pharmaceuticals (Basel). 2024 Jun 16;17(6):788. doi: 10.3390/ph17060788.
8
Virgin coconut oil (VCO) supplementation relieves symptoms and inflammation among COVID-19 positive adults: a single-blind randomized trial.初榨椰子油（VCO）补充剂可缓解 COVID-19 阳性成年人的症状和炎症：一项单盲随机试验。
J Nutr Sci. 2024 Jan 23;13:e5. doi: 10.1017/jns.2023.118. eCollection 2024.
9
SARS-Cov-2 Cycle Threshold Value and Olfactory Dysfunction in COVID-19 Patients.新冠病毒感染患者中新冠病毒2型的循环阈值与嗅觉功能障碍
Iran J Otorhinolaryngol. 2023 Sep;35(130):263-273. doi: 10.22038/IJORL.2023.71462.3429.
10
Olfactory and gustatory dysfunction, evaluation and the impact on quality of life among COVID-19 patients: a multi-centre study.新型冠状病毒肺炎患者嗅觉和味觉功能障碍、评估及其对生活质量的影响：一项多中心研究
Ann Med Surg (Lond). 2023 Sep 18;85(11):5403-5409. doi: 10.1097/MS9.0000000000001311. eCollection 2023 Nov.
本文引用的文献
1
SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）受体和进入基因在人嗅神经上皮和大脑中表达。
iScience. 2020 Dec 18;23(12):101839. doi: 10.1016/j.isci.2020.101839. Epub 2020 Nov 25.
2
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia.SARS-CoV-2 进入基因在嗅觉系统中的非神经元表达提示了 COVID-19 相关嗅觉丧失的潜在机制。
Sci Adv. 2020 Jul 31;6(31). doi: 10.1126/sciadv.abc5801. Epub 2020 Jul 24.
3
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.SARS-CoV-2 受体 ACE2 是人类气道上皮细胞中的一种干扰素刺激基因，可在组织中的特定细胞亚群中检测到。
Cell. 2020 May 28;181(5):1016-1035.e19. doi: 10.1016/j.cell.2020.04.035. Epub 2020 Apr 27.
4
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）进入因子与固有免疫基因一起在鼻上皮细胞中高表达。
Nat Med. 2020 May;26(5):681-687. doi: 10.1038/s41591-020-0868-6. Epub 2020 Apr 23.
5
Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection.轻度症状的 SARS-CoV-2 感染门诊患者的嗅觉或味觉改变。
JAMA. 2020 May 26;323(20):2089-2090. doi: 10.1001/jama.2020.6771.
6
Smell dysfunction: a biomarker for COVID-19.嗅觉功能障碍：COVID-19 的生物标志物。
Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950. doi: 10.1002/alr.22587. Epub 2020 Jun 18.
7
Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染所致嗅觉丧失的嗅球磁共振成像：首例报告
Acad Radiol. 2020 Jun;27(6):892-893. doi: 10.1016/j.acra.2020.04.002. Epub 2020 Apr 11.
8
Presentation of new onset anosmia during the COVID-19 pandemic.在 COVID-19 大流行期间出现新发嗅觉丧失。
Rhinology. 2020 Jun 1;58(3):295-298. doi: 10.4193/Rhin20.116.
9
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
10
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.嗅觉和味觉障碍作为冠状病毒病（COVID-19）轻至中度形式的临床特征：一项多中心欧洲研究。
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.
Zotero 插件